WO2012123383A3 - Composition de soin et/ou d'hygiene bucco-dentaire - Google Patents

Composition de soin et/ou d'hygiene bucco-dentaire Download PDF

Info

Publication number
WO2012123383A3
WO2012123383A3 PCT/EP2012/054176 EP2012054176W WO2012123383A3 WO 2012123383 A3 WO2012123383 A3 WO 2012123383A3 EP 2012054176 W EP2012054176 W EP 2012054176W WO 2012123383 A3 WO2012123383 A3 WO 2012123383A3
Authority
WO
WIPO (PCT)
Prior art keywords
chlorhexidine
care composition
composition
soluble salts
sodium docusate
Prior art date
Application number
PCT/EP2012/054176
Other languages
English (en)
Other versions
WO2012123383A2 (fr
Inventor
Jean-François CORDOLIANI
Jacques Dubois
Anne-Sophie Saurel
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of WO2012123383A2 publication Critical patent/WO2012123383A2/fr
Publication of WO2012123383A3 publication Critical patent/WO2012123383A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une composition comprenant de la chlorhexidine ou un de ses sels solubles et du docusate de sodium (DOS S) dans un rapport molaire chlorhexidine ou un de ses sels solubles / docusate de sodium égal à ½, dans un véhicule hydro alcoolique comprenant de 30 à 60% d'alcool (v/v) par rapport au volume total de la composition. Les compositions selon l'invention ont l'avantage de prolonger l'activité antimicrobienne de la chlorhexidine après utilisation (amélioration de la rémanence) et de réduire le phénomène de noircissement au niveau de la cavité buccale.
PCT/EP2012/054176 2011-03-11 2012-03-09 Composition de soin et/ou d'hygiene bucco-dentaire WO2012123383A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1152019 2011-03-11
FR1152019A FR2972347B1 (fr) 2011-03-11 2011-03-11 Composition de soin et/ou d'hygiene bucco-dentaire

Publications (2)

Publication Number Publication Date
WO2012123383A2 WO2012123383A2 (fr) 2012-09-20
WO2012123383A3 true WO2012123383A3 (fr) 2013-01-03

Family

ID=45811521

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/054176 WO2012123383A2 (fr) 2011-03-11 2012-03-09 Composition de soin et/ou d'hygiene bucco-dentaire

Country Status (2)

Country Link
FR (1) FR2972347B1 (fr)
WO (1) WO2012123383A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2775929A1 (fr) 2009-10-02 2011-04-07 Elka Touitou Compositions desinfectantes
IT201700022601A1 (it) * 2017-02-28 2018-08-28 Unifarco S P A Collutorio a base di clorexidina anti-imbrunimento dentale.
FR3065879B1 (fr) 2017-05-02 2020-11-20 Pf Medicament Composition antiseptique d'une association de chlorhexidine et d'iode

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683454A1 (fr) * 1991-11-13 1993-05-14 Pf Medicament Composition pharmaceutique bactericide.
EP0884948B1 (fr) * 1996-03-04 2001-12-19 Pierre Fabre Medicament Compositions antiseptiques a base de chlorobutanol et de chlorhexidine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683454A1 (fr) * 1991-11-13 1993-05-14 Pf Medicament Composition pharmaceutique bactericide.
EP0884948B1 (fr) * 1996-03-04 2001-12-19 Pierre Fabre Medicament Compositions antiseptiques a base de chlorobutanol et de chlorhexidine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"ELUDRIL SOLUTION ED - VIDAL L", 1 January 1987, DICTIONNAIRE VIDAL. 1995; [DICTIONNAIRE VIDAL], PARIS, EDITIONS DU VIDAL, FR, PAGE(S) 521, XP002018291 *
DATABASE GNPD [online] Mintel; February 2006 (2006-02-01), "Mouth Rinse Solution", XP002662971, Database accession no. 10253205 *

Also Published As

Publication number Publication date
WO2012123383A2 (fr) 2012-09-20
FR2972347A1 (fr) 2012-09-14
FR2972347B1 (fr) 2013-04-12

Similar Documents

Publication Publication Date Title
WO2015021382A3 (fr) Compositions topiques et procédés d'utilisation de celles-ci
WO2009077693A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene
WO2014186742A3 (fr) Composition d'hydrogel anhydre
CA2894892A1 (fr) Derives d'acide boronique et leurs utilisations therapeutiques
WO2008006528A3 (fr) Nouvelles compositions pharmaceutiques comprenant du lévétiracétam
WO2013067150A3 (fr) Composition ayant une activité antimicrobienne prolongée
WO2010072958A3 (fr) Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
WO2012104275A3 (fr) Systèmes d'administration de nanoparticules, leur préparation et leurs utilisations
WO2009109869A3 (fr) Compositions alcooliques antimicrobiennes pour désinfecter la peau comprenant des épaississants cationiques compatibles
WO2009100264A3 (fr) Produit de soins bucco-dentaires et méthodes d'utilisation dudit produit
WO2011017502A3 (fr) Formulations comprenant du linaclotide
WO2014108846A3 (fr) Composition cosmétique apaisante basée sur de l'acide salicylique
CA2891921C (fr) Compositions de soin oral stables en presence du peroxyde
WO2011106493A3 (fr) Compositions de soin buccal
WO2011100671A3 (fr) Procédés et compositions pour amélioration de résistance mécanique des dents
WO2007132134A3 (fr) Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations
WO2012001074A3 (fr) Compositions pharmaceutiques comprenant du lactate de 4-amino-5-fluoro-3-[6-(4-méthylpipérazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinoline-2-one monohydraté
HRP20171861T1 (hr) Dermatološki pripravak koji sadrži heparan sulfat
EP2347796A3 (fr) Particules composites pour une utilisation dans les soins buccaux
ATE501644T1 (de) Flüssige formulierungen enthaltend carotinoide
MX341274B (es) Formulaciones de enjuague bucal para ser usadas con un dispositivo de suministro en el cepillo de dientes.
WO2010041832A3 (fr) Composition antioxydante active contenant un composé dériivé d'ishige okamurae
BR112013021391A2 (pt) pré-misturas de sabor para goma de mascar, métodos para fazer pré-misturas de sabor e composições de goma de mascar das mesmas
WO2012123383A3 (fr) Composition de soin et/ou d'hygiene bucco-dentaire
WO2010017885A3 (fr) Utilisation d'acide 5-(7-méthoxy-3,3-diméthyl-2,3-dihydro-1-benzoxépin-5-yl)-3-méthyl-penta-2,4-diénoïque comme produit cosmétique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12707788

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12707788

Country of ref document: EP

Kind code of ref document: A2